Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 227.7%.
Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 227.7%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.